Page last updated: 2024-09-04

ezetimibe and Diabetic Cardiomyopathies

ezetimibe has been researched along with Diabetic Cardiomyopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grant, PJ	1

Other Studies

1 other study(ies) available for ezetimibe and Diabetic Cardiomyopathies

Article	Year
PCSK9 inhibitors- A new age in lipid management? Diabetes & vascular disease research, 2017, Volume: 14, Issue:3 Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; PCSK9 Inhibitors; Proprotein Convertase 9; Randomized Controlled Trials as Topic; Risk; Serine Proteinase Inhibitors	2017

Article

Year

PCSK9 inhibitors- A new age in lipid management?

Diabetes & vascular disease research, 2017, Volume: 14, Issue:3

Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; PCSK9 Inhibitors; Proprotein Convertase 9; Randomized Controlled Trials as Topic; Risk; Serine Proteinase Inhibitors

2017